Success Metrics

Clinical Success Rate
94.7%

Based on 126 completed trials

Completion Rate
95%(126/133)
Active Trials
9(6%)
Results Posted
29%(36 trials)
Terminated
7(4%)

Phase Distribution

Ph phase_1
44
28%
Ph phase_4
16
10%
Ph not_applicable
29
18%
Ph phase_2
26
17%
Ph phase_3
36
23%

Phase Distribution

44

Early Stage

26

Mid Stage

52

Late Stage

Phase Distribution151 total trials
Phase 1Safety & dosage
44(29.1%)
Phase 2Efficacy & side effects
26(17.2%)
Phase 3Large-scale testing
36(23.8%)
Phase 4Post-market surveillance
16(10.6%)
N/ANon-phased studies
29(19.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.6%

126 of 136 finished

Non-Completion Rate

7.4%

10 ended early

Currently Active

9

trials recruiting

Total Trials

157

all time

Status Distribution
Active(10)
Completed(126)
Terminated(10)
Other(11)

Detailed Status

Completed126
unknown11
Recruiting9
Terminated7
Withdrawn3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
157
Active
9
Success Rate
94.7%
Most Advanced
Phase 4

Trials by Phase

Phase 144 (29.1%)
Phase 226 (17.2%)
Phase 336 (23.8%)
Phase 416 (10.6%)
N/A29 (19.2%)

Trials by Status

not_yet_recruiting11%
terminated74%
unknown117%
completed12680%
recruiting96%
withdrawn32%

Recent Activity

Clinical Trials (157)

Showing 20 of 157 trialsScroll for more
NCT07636018Phase 1

A Study to Learn if the Study Medicine Called Fluconazole Changes How the Other Body Processes the Study Medicine PF-07248144

Completed
NCT05421858Phase 3

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.

Recruiting
NCT07439250Phase 1

A Study of Olomorasib (LY3537982) in Healthy Participants

Completed
NCT05076409Phase 1

A Study in Healthy Men to Test How Fluconazole Influences the Amount of BI 425809 in the Blood

Completed
NCT03945448Phase 2

Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia

Recruiting
NCT07341672Phase 1

A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants

Not Yet Recruiting
NCT02997059Phase 2

Effect of Fluconazole on the Levels of ASCA After Surgical Resection for Crohn's Disease.

Completed
NCT04368559Phase 3

Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation

Completed
NCT07395024Phase 1

A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Healthy Adults

Recruiting
NCT05178862Phase 3

A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole

Terminated
NCT03828773Not Applicable

PTX3-targeted Antifungal Prophylaxis

Recruiting
NCT06274554Phase 3

Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease

Recruiting
NCT02145832Phase 2

Fluconazole Versus Micafungin in Neonates With Candidiasis

Completed
NCT06847464Phase 1

A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323.

Completed
NCT06345794Phase 1

A Study to Assess LY4100511 (DC-853) in Healthy Adult Participants

Completed
NCT06922344Phase 4

Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor

Recruiting
NCT06822166Phase 1

Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride

Completed
NCT03135106Phase 1

A Study to Evaluate the Effect of Fluconazole and Itraconazole on Erdafitinib Pharmacokinetics in Healthy Adult Participants

Completed
NCT06770530Phase 4

Introduction of Mycotic Prophylaxis At Cystectomy Trial.

Recruiting
NCT06709196Phase 4

Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
157